Arbor Rapha Capital Bioholdings Corp. I
Status: Liquidated
U=S+W/3
W=S@11.50
| IPO Proceeds, $M | $172.50M |
|---|---|
| IPO Date | Oct 29, 2021 |
| CEO | Ivan Kaufman |
| Left Lead | Cantor Fitzgerald |
| IPO Cash in Trust | 102.5% |
| SPAC Tenor | 15 + 6 |
| IPO Sector |
Healthcare
Biopharmaceutical sector, with a focus on disruptive technologies |
| IPO Geography | Global |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Mar 3, 2023 |
| Closing Date | Mar 7, 2023 |
ARCK
ARCKU
ARCKW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Arbor Rapha Capital Bioholdings Corp. I:
- Structure and cap table
- 8 directors & officers
- 13 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Ivan Kaufman | 60 | Chief Executive Officer, President and Director |
| Kevin Slawin | 60 | Chief Strategy Officer and Director |
| Paul Elenio | 54 | Chief Financial Officer |
| William Connolly | 44 | Secretary & Vice President |
| John Natalone | 56 | Treasurer |
| Cyrus D. Walker | 54 | Director |
| Ralph Mack | 61 | Director |
| Avery Modlin | 50 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
| Underwriters | |||
|---|---|---|---|
| Cantor Fitzgerald | BR | 15,000,000 | units |
| 15,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.